Dana-Farber prevails in immunotherapy dispute over patents

Dana-Farber prevails in immunotherapy dispute over patents

STAT Plus: Dana-Farber prevails in immunotherapy dispute over patents behind blockbuster drug

By ELIZABETH COONEY

SUZANNE KREITER/THE BOSTON GLOBE

A court ruling will allow Dana-Farber to license the intellectual property behind the patents to companies developing new therapies.

READ MORE